 | • レポートコード：MRC2-11QY11927 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は女性用不妊症診断・治療のグローバル市場について調査・分析したレポートです。種類別（治療剤・薬品、手術、子宮内授精（IUI）、生殖補助医療（ART））市場規模、用途別（病院・クリニック、診断センター）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別女性用不妊症診断・治療の競争状況、市場シェア ・世界の女性用不妊症診断・治療市場：種類別市場規模 2015年-2020年（治療剤・薬品、手術、子宮内授精（IUI）、生殖補助医療（ART）） ・世界の女性用不妊症診断・治療市場：種類別市場規模予測 2021年-2026年（治療剤・薬品、手術、子宮内授精（IUI）、生殖補助医療（ART）） ・世界の女性用不妊症診断・治療市場：用途別市場規模 2015年-2020年（病院・クリニック、診断センター） ・世界の女性用不妊症診断・治療市場：用途別市場規模予測 2021年-2026年（病院・クリニック、診断センター） ・北米の女性用不妊症診断・治療市場分析：米国、カナダ ・ヨーロッパの女性用不妊症診断・治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの女性用不妊症診断・治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の女性用不妊症診断・治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの女性用不妊症診断・治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer、Bristol-Myers Squibb、Church & Dwight、Cook Medical、CooperSurgical、Eli Lilly、EMD Serono、Endo、Ferring Pharmaceuticals、Genea、GSK、Halotech DNA、Irvine Scientific、Janssen、Merck、Novartis、Origio、Pfizer、OvaScience ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Female infertility refers to infertility in female humans.
The major factors that are augmenting the growth of the female infertility market are changing life style and increasing IVF market. Furthermore, rising trend of surrogacy, growing infertility rate among female, new technologies to avoid multiple embryo implants are the also estimated to be the major factors that are contributing significantly towards the growth of the market.
Market Analysis and Insights: Global Female Infertility Diagnosis and Treatment Market
The global Female Infertility Diagnosis and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Female Infertility Diagnosis and Treatment Scope and Market Size
Female Infertility Diagnosis and Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Female Infertility Diagnosis and Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bayer
Bristol-Myers Squibb
Church & Dwight
Cook Medical
CooperSurgical
Eli Lilly
EMD Serono
Endo
Ferring Pharmaceuticals
Genea
GSK
Halotech DNA
Irvine Scientific
Janssen
Merck
Novartis
Origio
Pfizer
OvaScience
Market segment by Type, the product can be split into
Drugs and medicine
Surgical
Intrauterine insemination (IUI)
Assisted reproductive technology (ART)
Market segment by Application, split into
Hospitals and Clinics
Diagnostic Centers
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Female Infertility Diagnosis and Treatment Revenue
1.4 Market by Type
1.4.1 Global Female Infertility Diagnosis and Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Drugs and medicine
1.4.3 Surgical
1.4.4 Intrauterine insemination (IUI)
1.4.5 Assisted reproductive technology (ART)
1.5 Market by Application
1.5.1 Global Female Infertility Diagnosis and Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals and Clinics
1.5.3 Diagnostic Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Female Infertility Diagnosis and Treatment Market Perspective (2015-2026)
2.2 Global Female Infertility Diagnosis and Treatment Growth Trends by Regions
2.2.1 Female Infertility Diagnosis and Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Female Infertility Diagnosis and Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Female Infertility Diagnosis and Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Female Infertility Diagnosis and Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Female Infertility Diagnosis and Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Female Infertility Diagnosis and Treatment Players by Market Size
3.1.1 Global Top Female Infertility Diagnosis and Treatment Players by Revenue (2015-2020)
3.1.2 Global Female Infertility Diagnosis and Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Female Infertility Diagnosis and Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Female Infertility Diagnosis and Treatment Market Concentration Ratio
3.2.1 Global Female Infertility Diagnosis and Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Female Infertility Diagnosis and Treatment Revenue in 2019
3.3 Female Infertility Diagnosis and Treatment Key Players Head office and Area Served
3.4 Key Players Female Infertility Diagnosis and Treatment Product Solution and Service
3.5 Date of Enter into Female Infertility Diagnosis and Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Female Infertility Diagnosis and Treatment Historic Market Size by Type (2015-2020)
4.2 Global Female Infertility Diagnosis and Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Female Infertility Diagnosis and Treatment Market Size by Application (2015-2020)
5.2 Global Female Infertility Diagnosis and Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Female Infertility Diagnosis and Treatment Market Size (2015-2020)
6.2 Female Infertility Diagnosis and Treatment Key Players in North America (2019-2020)
6.3 North America Female Infertility Diagnosis and Treatment Market Size by Type (2015-2020)
6.4 North America Female Infertility Diagnosis and Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Female Infertility Diagnosis and Treatment Market Size (2015-2020)
7.2 Female Infertility Diagnosis and Treatment Key Players in Europe (2019-2020)
7.3 Europe Female Infertility Diagnosis and Treatment Market Size by Type (2015-2020)
7.4 Europe Female Infertility Diagnosis and Treatment Market Size by Application (2015-2020)
8 China
8.1 China Female Infertility Diagnosis and Treatment Market Size (2015-2020)
8.2 Female Infertility Diagnosis and Treatment Key Players in China (2019-2020)
8.3 China Female Infertility Diagnosis and Treatment Market Size by Type (2015-2020)
8.4 China Female Infertility Diagnosis and Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Female Infertility Diagnosis and Treatment Market Size (2015-2020)
9.2 Female Infertility Diagnosis and Treatment Key Players in Japan (2019-2020)
9.3 Japan Female Infertility Diagnosis and Treatment Market Size by Type (2015-2020)
9.4 Japan Female Infertility Diagnosis and Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Female Infertility Diagnosis and Treatment Market Size (2015-2020)
10.2 Female Infertility Diagnosis and Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Female Infertility Diagnosis and Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Female Infertility Diagnosis and Treatment Market Size by Application (2015-2020)
11 India
11.1 India Female Infertility Diagnosis and Treatment Market Size (2015-2020)
11.2 Female Infertility Diagnosis and Treatment Key Players in India (2019-2020)
11.3 India Female Infertility Diagnosis and Treatment Market Size by Type (2015-2020)
11.4 India Female Infertility Diagnosis and Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Female Infertility Diagnosis and Treatment Market Size (2015-2020)
12.2 Female Infertility Diagnosis and Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Female Infertility Diagnosis and Treatment Market Size by Type (2015-2020)
12.4 Central & South America Female Infertility Diagnosis and Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bayer
13.1.1 Bayer Company Details
13.1.2 Bayer Business Overview
13.1.3 Bayer Female Infertility Diagnosis and Treatment Introduction
13.1.4 Bayer Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020))
13.1.5 Bayer Recent Development
13.2 Bristol-Myers Squibb
13.2.1 Bristol-Myers Squibb Company Details
13.2.2 Bristol-Myers Squibb Business Overview
13.2.3 Bristol-Myers Squibb Female Infertility Diagnosis and Treatment Introduction
13.2.4 Bristol-Myers Squibb Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020)
13.2.5 Bristol-Myers Squibb Recent Development
13.3 Church & Dwight
13.3.1 Church & Dwight Company Details
13.3.2 Church & Dwight Business Overview
13.3.3 Church & Dwight Female Infertility Diagnosis and Treatment Introduction
13.3.4 Church & Dwight Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020)
13.3.5 Church & Dwight Recent Development
13.4 Cook Medical
13.4.1 Cook Medical Company Details
13.4.2 Cook Medical Business Overview
13.4.3 Cook Medical Female Infertility Diagnosis and Treatment Introduction
13.4.4 Cook Medical Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020)
13.4.5 Cook Medical Recent Development
13.5 CooperSurgical
13.5.1 CooperSurgical Company Details
13.5.2 CooperSurgical Business Overview
13.5.3 CooperSurgical Female Infertility Diagnosis and Treatment Introduction
13.5.4 CooperSurgical Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020)
13.5.5 CooperSurgical Recent Development
13.6 Eli Lilly
13.6.1 Eli Lilly Company Details
13.6.2 Eli Lilly Business Overview
13.6.3 Eli Lilly Female Infertility Diagnosis and Treatment Introduction
13.6.4 Eli Lilly Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020)
13.6.5 Eli Lilly Recent Development
13.7 EMD Serono
13.7.1 EMD Serono Company Details
13.7.2 EMD Serono Business Overview
13.7.3 EMD Serono Female Infertility Diagnosis and Treatment Introduction
13.7.4 EMD Serono Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020)
13.7.5 EMD Serono Recent Development
13.8 Endo
13.8.1 Endo Company Details
13.8.2 Endo Business Overview
13.8.3 Endo Female Infertility Diagnosis and Treatment Introduction
13.8.4 Endo Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020)
13.8.5 Endo Recent Development
13.9 Ferring Pharmaceuticals
13.9.1 Ferring Pharmaceuticals Company Details
13.9.2 Ferring Pharmaceuticals Business Overview
13.9.3 Ferring Pharmaceuticals Female Infertility Diagnosis and Treatment Introduction
13.9.4 Ferring Pharmaceuticals Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020)
13.9.5 Ferring Pharmaceuticals Recent Development
13.10 Genea
13.10.1 Genea Company Details
13.10.2 Genea Business Overview
13.10.3 Genea Female Infertility Diagnosis and Treatment Introduction
13.10.4 Genea Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020)
13.10.5 Genea Recent Development
13.11 GSK
10.11.1 GSK Company Details
10.11.2 GSK Business Overview
10.11.3 GSK Female Infertility Diagnosis and Treatment Introduction
10.11.4 GSK Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020)
10.11.5 GSK Recent Development
13.12 Halotech DNA
10.12.1 Halotech DNA Company Details
10.12.2 Halotech DNA Business Overview
10.12.3 Halotech DNA Female Infertility Diagnosis and Treatment Introduction
10.12.4 Halotech DNA Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020)
10.12.5 Halotech DNA Recent Development
13.13 Irvine Scientific
10.13.1 Irvine Scientific Company Details
10.13.2 Irvine Scientific Business Overview
10.13.3 Irvine Scientific Female Infertility Diagnosis and Treatment Introduction
10.13.4 Irvine Scientific Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020)
10.13.5 Irvine Scientific Recent Development
13.14 Janssen
10.14.1 Janssen Company Details
10.14.2 Janssen Business Overview
10.14.3 Janssen Female Infertility Diagnosis and Treatment Introduction
10.14.4 Janssen Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020)
10.14.5 Janssen Recent Development
13.15 Merck
10.15.1 Merck Company Details
10.15.2 Merck Business Overview
10.15.3 Merck Female Infertility Diagnosis and Treatment Introduction
10.15.4 Merck Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020)
10.15.5 Merck Recent Development
13.16 Novartis
10.16.1 Novartis Company Details
10.16.2 Novartis Business Overview
10.16.3 Novartis Female Infertility Diagnosis and Treatment Introduction
10.16.4 Novartis Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020)
10.16.5 Novartis Recent Development
13.17 Origio
10.17.1 Origio Company Details
10.17.2 Origio Business Overview
10.17.3 Origio Female Infertility Diagnosis and Treatment Introduction
10.17.4 Origio Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020)
10.17.5 Origio Recent Development
13.18 Pfizer
10.18.1 Pfizer Company Details
10.18.2 Pfizer Business Overview
10.18.3 Pfizer Female Infertility Diagnosis and Treatment Introduction
10.18.4 Pfizer Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020)
10.18.5 Pfizer Recent Development
13.19 OvaScience
10.19.1 OvaScience Company Details
10.19.2 OvaScience Business Overview
10.19.3 OvaScience Female Infertility Diagnosis and Treatment Introduction
10.19.4 OvaScience Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020)
10.19.5 OvaScience Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Female Infertility Diagnosis and Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Female Infertility Diagnosis and Treatment Revenue
Table 3. Ranking of Global Top Female Infertility Diagnosis and Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Female Infertility Diagnosis and Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drugs and medicine
Table 6. Key Players of Surgical
Table 7. Key Players of Intrauterine insemination (IUI)
Table 8. Key Players of Assisted reproductive technology (ART)
Table 9. Global Female Infertility Diagnosis and Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Female Infertility Diagnosis and Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Female Infertility Diagnosis and Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Female Infertility Diagnosis and Treatment Market Share by Regions (2015-2020)
Table 13. Global Female Infertility Diagnosis and Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Female Infertility Diagnosis and Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Female Infertility Diagnosis and Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Female Infertility Diagnosis and Treatment Players
Table 20. Global Female Infertility Diagnosis and Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Female Infertility Diagnosis and Treatment Market Share by Players (2015-2020)
Table 22. Global Top Female Infertility Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Infertility Diagnosis and Treatment as of 2019)
Table 23. Global Female Infertility Diagnosis and Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Female Infertility Diagnosis and Treatment Product Solution and Service
Table 26. Date of Enter into Female Infertility Diagnosis and Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Female Infertility Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Female Infertility Diagnosis and Treatment Market Size Share by Type (2015-2020)
Table 30. Global Female Infertility Diagnosis and Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Female Infertility Diagnosis and Treatment Market Size Share by Application (2015-2020)
Table 32. Global Female Infertility Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Female Infertility Diagnosis and Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Female Infertility Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Female Infertility Diagnosis and Treatment Market Share (2019-2020)
Table 36. North America Female Infertility Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Female Infertility Diagnosis and Treatment Market Share by Type (2015-2020)
Table 38. North America Female Infertility Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Female Infertility Diagnosis and Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Female Infertility Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Female Infertility Diagnosis and Treatment Market Share (2019-2020)
Table 42. Europe Female Infertility Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Female Infertility Diagnosis and Treatment Market Share by Type (2015-2020)
Table 44. Europe Female Infertility Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Female Infertility Diagnosis and Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Female Infertility Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Female Infertility Diagnosis and Treatment Market Share (2019-2020)
Table 48. China Female Infertility Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Female Infertility Diagnosis and Treatment Market Share by Type (2015-2020)
Table 50. China Female Infertility Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Female Infertility Diagnosis and Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Female Infertility Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Female Infertility Diagnosis and Treatment Market Share (2019-2020)
Table 54. Japan Female Infertility Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Female Infertility Diagnosis and Treatment Market Share by Type (2015-2020)
Table 56. Japan Female Infertility Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Female Infertility Diagnosis and Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Female Infertility Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Female Infertility Diagnosis and Treatment Market Share (2019-2020)
Table 60. Southeast Asia Female Infertility Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Female Infertility Diagnosis and Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Female Infertility Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Female Infertility Diagnosis and Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Female Infertility Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Female Infertility Diagnosis and Treatment Market Share (2019-2020)
Table 66. India Female Infertility Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Female Infertility Diagnosis and Treatment Market Share by Type (2015-2020)
Table 68. India Female Infertility Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Female Infertility Diagnosis and Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Female Infertility Diagnosis and Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Female Infertility Diagnosis and Treatment Market Share (2019-2020)
Table 72. Central & South America Female Infertility Diagnosis and Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Female Infertility Diagnosis and Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Female Infertility Diagnosis and Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Female Infertility Diagnosis and Treatment Market Share by Application (2015-2020)
Table 76. Bayer Company Details
Table 77. Bayer Business Overview
Table 78. Bayer Product
Table 79. Bayer Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 80. Bayer Recent Development
Table 81. Bristol-Myers Squibb Company Details
Table 82. Bristol-Myers Squibb Business Overview
Table 83. Bristol-Myers Squibb Product
Table 84. Bristol-Myers Squibb Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 85. Bristol-Myers Squibb Recent Development
Table 86. Church & Dwight Company Details
Table 87. Church & Dwight Business Overview
Table 88. Church & Dwight Product
Table 89. Church & Dwight Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 90. Church & Dwight Recent Development
Table 91. Cook Medical Company Details
Table 92. Cook Medical Business Overview
Table 93. Cook Medical Product
Table 94. Cook Medical Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 95. Cook Medical Recent Development
Table 96. CooperSurgical Company Details
Table 97. CooperSurgical Business Overview
Table 98. CooperSurgical Product
Table 99. CooperSurgical Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 100. CooperSurgical Recent Development
Table 101. Eli Lilly Company Details
Table 102. Eli Lilly Business Overview
Table 103. Eli Lilly Product
Table 104. Eli Lilly Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 105. Eli Lilly Recent Development
Table 106. EMD Serono Company Details
Table 107. EMD Serono Business Overview
Table 108. EMD Serono Product
Table 109. EMD Serono Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 110. EMD Serono Recent Development
Table 111. Endo Business Overview
Table 112. Endo Product
Table 113. Endo Company Details
Table 114. Endo Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 115. Endo Recent Development
Table 116. Ferring Pharmaceuticals Company Details
Table 117. Ferring Pharmaceuticals Business Overview
Table 118. Ferring Pharmaceuticals Product
Table 119. Ferring Pharmaceuticals Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 120. Ferring Pharmaceuticals Recent Development
Table 121. Genea Company Details
Table 122. Genea Business Overview
Table 123. Genea Product
Table 124. Genea Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 125. Genea Recent Development
Table 126. GSK Company Details
Table 127. GSK Business Overview
Table 128. GSK Product
Table 129. GSK Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 130. GSK Recent Development
Table 131. Halotech DNA Company Details
Table 132. Halotech DNA Business Overview
Table 133. Halotech DNA Product
Table 134. Halotech DNA Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 135. Halotech DNA Recent Development
Table 136. Irvine Scientific Company Details
Table 137. Irvine Scientific Business Overview
Table 138. Irvine Scientific Product
Table 139. Irvine Scientific Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 140. Irvine Scientific Recent Development
Table 141. Janssen Company Details
Table 142. Janssen Business Overview
Table 143. Janssen Product
Table 144. Janssen Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 145. Janssen Recent Development
Table 146. Merck Company Details
Table 147. Merck Business Overview
Table 148. Merck Product
Table 149. Merck Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 150. Merck Recent Development
Table 151. Novartis Company Details
Table 152. Novartis Business Overview
Table 153. Novartis Product
Table 154. Novartis Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 155. Novartis Recent Development
Table 156. Origio Company Details
Table 157. Origio Business Overview
Table 158. Origio Product
Table 159. Origio Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 160. Origio Recent Development
Table 161. Pfizer Company Details
Table 162. Pfizer Business Overview
Table 163. Pfizer Product
Table 164. Pfizer Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 165. Pfizer Recent Development
Table 166. OvaScience Company Details
Table 167. OvaScience Business Overview
Table 168. OvaScience Product
Table 169. OvaScience Revenue in Female Infertility Diagnosis and Treatment Business (2015-2020) (Million US$)
Table 170. OvaScience Recent Development
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Female Infertility Diagnosis and Treatment Market Share by Type: 2020 VS 2026
Figure 2. Drugs and medicine Features
Figure 3. Surgical Features
Figure 4. Intrauterine insemination (IUI) Features
Figure 5. Assisted reproductive technology (ART) Features
Figure 6. Global Female Infertility Diagnosis and Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals and Clinics Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Female Infertility Diagnosis and Treatment Report Years Considered
Figure 10. Global Female Infertility Diagnosis and Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Female Infertility Diagnosis and Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Female Infertility Diagnosis and Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Female Infertility Diagnosis and Treatment Market Share by Players in 2019
Figure 15. Global Top Female Infertility Diagnosis and Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Female Infertility Diagnosis and Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Female Infertility Diagnosis and Treatment Revenue in 2019
Figure 17. North America Female Infertility Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Female Infertility Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Female Infertility Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Female Infertility Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Female Infertility Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Female Infertility Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Female Infertility Diagnosis and Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
男性不妊症診断・治療の世界市場（～2026年） Male infertility refers to a male's inability to cause pregnancy in a fertile female. The major factors that are augmenting the growth of the market are estimated to be increasing alcohol consumption, increasing age, rising environmental pollution etc. Additionally, increasing stress, changing life …- 不妊症診断の世界市場（～2026年） Fertility diagnosis is done by both men and women for the evaluation of their fertility and various conditions associated with it. The assessment of infertility proceeds along simple and logical lines which includes test for eggs, test for sperm, and how they can get together. Additional tests are p…
- 不妊検査・治療の世界市場（～2026年） Fertility testing is done by both men and women for the evaluation of their fertility and various conditions associated with it. The assessment of infertility proceeds along simple and logical lines which includes test for eggs, test for sperm, and how they can get together. Additional tests are per…
- 不妊治療の世界市場（～2026年） Market Analysis and Insights: Global Infertility Treatment Market The global Infertility Treatment market size is projected to reach US$ 1458 million by 2026, from US$ 1364.8 million in 2020, at a CAGR of 6.3%% during 2021-2026. Global Infertility Treatment Scope and Market Size Infertility Treatmen…
- 不妊症サービスの世界市場（～2026年） In humans, infertility is the inability to become pregnant or carry a pregnancy to full term. There are many causes of infertility, including some that medical intervention can treat. Some infertility services include Assisted Reproductive Technology (ART), Infertility drug services, Artificial Inse…